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PREFACE 
Despite the mul t id i rec t iona l improvements in programme 
towards protect ing the health of vast population of India, our socio-
economic status part icularly in rural populat ion, is far f rom sat is factory. 
This factor is possibly responsible for the great risk of helminthic 
infections to teaming mil l ions. 
Among the helminthic diseases of man, ancylostomiasis or 
the hookworm disease occupies a signif icant posit ion f rom the point 
of human misery and economic losses. Due to various drawbacks 
of existing an!:ihookvi/orm agents, atempts in the present study have 
been made to f ind out better ^nt ihookworm agents w/ith high cure 
rate and safety for mass appl icat ion. 
A programme of research, ident i f ied for Ph.D. thesis w/ork 
is concerned w i t h this national problem and prel iminary results o ' 
the envisaged plan of work have been compiled for the M.Phi l , dis-
sertat ion. 
INTRODUCTION 
Helminth parasites continue to be of major global 
public health concern because of their very high preva-
lence and their adverse effects on the immune and nutri-
tional status of the population. Prevalence of these 
parasites is frequently over^looked in temperate regions 
where they are less common and their effects are less 
marked than in the tropics and subtropics (Hruzik et al,. 
1977), During the past half century, however, there has 
been a serious realization of the extent and gravity of 
human helminthiasis and of the fact that they are unremit-
tingly corrossive, constituting a steady drain on the vit-
ality of the host and lowering often fatally, his resistance 
to other diseases even though they are hardly sufficient to 
cause death of the host. 
Amcmg the various helminthic infections, ancylostomiasis 
is a major disease of mankind from the point of human misery 
and economic loss (Faust and Russell^1964), Prevalence of 
the disease is very high in agricultural areas (Raghavan, 
1967) where the favourable soil temperature (between 23°-33°C 
and high percentage of humidity provide ideal condition for 
the growth and survival of infective larvae (Van den Bossche, 
1980) and where the people generally walk barefoot allowing 
the larvae to enter through the uncovered skin. 
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Pathogenic hookworm species: 
In nan: 
Ancvlostoma duodenale 
Necator americanus 
Ancvlostoma cevlanicuro 
In livestock and wild carnivores: 
Ancvlostoma brasiliense (dog and cat) 
A. kusimeanse (badger and dog) 
A, tubaeformis (cat) 
A. paraduodenase (lion and related carnivores) 
GairToeria pachvscelis (sheep and goat) 
Uncinaria spp. (dog, cat, foxes, wolves, 
domestic pig and northern 
furseal) 
Geograrhical distribution: 
The incidence of ancylostoroiasis is worldwide, being 
more intense in the rural parts of the tropical and subtro-
pical countries. According to a rough estimate by Stoll 
(1962), CCTA/WHO (1963) about 21% of the world population 
harbours hookworms. The more recent figures indicate that 
the number of infected persons ranged between 726 and 907 
millions (Davis 1973; Janssen, 1974; Standen 1975 and 
Mc Ginty 1979). Out of these 359 million reside in Asia, 
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208 in USSR, 1,4 in Europe, 49 in Africa, 42 in tropical 
America and aboxjt 1.8 million in north America. 
In the Asian continent, the endemic countries are India, 
Malaysia, China and Japan. However, the disease is also 
quite prevalent in Pakistan, Burma, Sri Lanka, Bangladesh, 
Nepal, Turkey. Morocco, Algeria, Iran, The Arabian peninsula, 
Hongkong, etc., (Chandler and Read, 1961; Fain, 1980). 
In India, the tropical climate, poor hygienic conditions 
and poorer health education provide ideal conditions for grow-
th, multiplication and dissemination of the parasite. The in-
cidence of hookworms has been reported to exceed 90^ in tea 
and coffee cultivating areas (Arora et^ al,., 1976; Gaitonde 
and Renapurkar, 1979), The states with heavy infectic»is are 
Assam, Maharashtra, Andhra Pradesh, Bihar, Kamataka, Kerala, 
Tamil Nadu and West Bengal whereas mild infections occur in 
Uttar Pradesh (20.151^ ) (Yunus, 1977), and Pondicheri (26,856) 
(Singh et al., 1978). 
Signs and Symptoms; 
The parasites are voracious blood feeders causing severe 
anaemia and various other disorders associated with it (Areekul, 
1^ 577; Lorenzi and Jamra, 1978; Akinkugbe, 1980; Loureirc et al.., 
1?83), such as digestive disturbances, gastrointestinal ulcera-
tions (Tand on et al.,, 1966), creeping eruption, pneumonitis and 
bronchospasms (Meyes and Neafie, 1976), The parasites also 
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cause endocrine disturbances resulting in delayed puberty 
and partial impotency (Faust and Russell, 1964), myocord-
ial aUements (Porter, 1937) and physical and mental retar* 
dation (Smillie et al.., 1926). In pregnancy the infections 
may be associated with changes in renal function, resulting 
to toxic conditions and albuminuria (Faust and Russell,1964). 
In chronic hookworm infections, haemoglobin level drops 
down to 49^  (Foy and Kondi, 1957) and erythropounts become 10 
mm (Brumpt 1958), Prolong chronic anaemia produces dulness, 
depression, confusion, poor memory and dizziness (Arora,195l), 
optical illusion, general nervousness and weakness (Flemming, 
1982). 
Pathogenic effects; 
The pathology caused by hookworm parasites depends upon 
the stage of the parasite and the organ infested. 
Pathology due to infective larvae: 
The larvae while entering the host through skin cause 
little mechanical damage, but as they burrow down into the 
blood capillary beds, considerable damage to tissues occurs. 
If the pathogenic bacteria is also associated with the larvae, 
open lesions often develop, ending to ground itth (dermatitis 
or watersore). 
The filariform larvae of non-human species, if happen "to 
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penetrate the human skin, wander aimlessly for long because 
of physiological barrier and produce reddish itchy papules al-
ong the path traversed by them (Chatterjee, 1967), This phe-
nomenon is called creeping eruption (Meyers and Neefie, 1976; 
Cypers, 1982), During migration through the brancho-oesopha-
geal route, microscopic damage is produced at the site where 
the larvae break open blood capillaries and reach air sacs re-
sulting in pneumonitis, bronchospasms and cough. 
Pathology due to adult worms: 
The adult parasites inhabit the small intestine (jejunum) 
attaching themselves to the mucous membrane by means of their 
buccal armature. A single parasite may consume on an average 
0.15-0.23 ml of blood each day from its host (Ho'agland and 
Schad, 1978). A patient harbouring about 100 worms, would 
loose approximately 15 ml of blood per day. The blood loss 
from 1 million cases would be 15,000 litres and world blood 
loss would be nearly 12 million litres per day. Riva et al,. 
(1981) noticed acute massive intestinal bleeding in hookworm 
infection. Haemoglobin deficiency resulting into a hypochro-
mic microcytic anaemia is the main feature of hookworm infe-
ction (Lee, 1975; Zuna et al., 1978; Areekul^1979; 1980; 
Gupta et al.., 198C; Foy and Kondi, 1931; Fleraming, 1982; 
Variyam and Banwell, 1982) whereas the deficiency of folic 
acid and vitamin 312 produce macrocytic hyperchromicanaemia 
(Viera, ' • 1980). The amount of iron loss through intesti-
nal haemorrhage varies from 3,9 to 18J.mg/day depending on 
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the intensity of the infection (Maspes and TaraTigaki 1979; 
1980). 
Objective and scope of the present work; 
Literature retrieval indicates seriousness of the di-
sease and warrants deep and concerted efforts to overcome 
the parasitic scourge. In recent past though a number of 
promising anthelmintics have been developed as antihookworm 
drugs and these are being successfully used for the treat-
ment of ancylostomiasis of man and domestic animals, none 
however appears to be perfect as they have one or the other 
shortcoming. Bephenium hydroxy napthoate (Alcopar^—') has 
species specific toxicity (Komiya et aJL,, 1960b; Hsieh,1970), 
bitoscanate (Zonit^-^) frequently causes severe digestive 
disorders (Lammler and Saupe, 1969), pyrantel pamoate does 
not exert equal action against the two human hookworms 
(Huggins et al,., 1973) and has many side effects (Kale, 1977), 
levamisole (Veraisole^ -S-') and tetramisole (Decaris^-^) are 
mainly effective against adult parasites (Thienpont et al», 
1970) and mebendazole (Mebex^—'), the drug of choice, also 
Alcopar;—' - Burrough's Welcome (India) 
Zonit® - (Bitoscanate) - Hoechst (India) 
Vermisol'^- Khandelwal Lab. Pvt. Ltd. 
Decaris® - Ethnor Ltd. (India). 
Mebex® - Cipla (India). 
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has limitations since the drug exerts embryotoxic and terato-
genic effects (Annon, 1975). Therefore, this is not indicated 
during pregnancy and in children of tender age (Keystone and 
Murdoch, 1979). 
Thus, the need of the day is to develop an effective and 
nontoxic antihookworm agent(s) with high curative rate. Be-
cause of polyparasitism frequently occurring in the populat-
ion, a drug with wide spectrum anthelmintic activity will have 
preference. The prophylactic action, if possessed by a drug, 
would be an added advantage in minimising the risk of reinfe-
ction. It is therefore proposed to screen a large number of 
plant extracts and rationally synthesized antihookworm compo-
unds for their chemotherapeutic potential. 
The true human hookworms are Ancylostoma duodenale and 
Necator americanus. Attempts to adapt N, americanus in ham-
sters have been successful, however, these necessitate the 
use of immunosuppressive drug, hydrocortisone (Sen et^  al*» 
1965). The forced parasitism using immunosuppressant is like-
ly to change the genetic make up of the parasite (Kirsch, 197^) 
resulting in altered immunological and chemotherapeutic res-
ponses and as such should be avoided. A. ceylanicuro is a hook-
worm parasite of dog, cat and roan and has easy adaptibility in 
laboratory host hamsters (Ray and Bhopale, 1972). Further its 
direct and short life cycle and positive chemotherapeutic cor-
relation between experimental and target parasites (Misra et al.. 
1981; Katiyar et al., 1984) add to the selection of A. ceylani-
curo as the test parasite. 
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RBVIBW OP LITERATURE 
Though the use of anthelmintics dates back to 1500 B.C., 
very little progress was made till late fifties in the deve-
lopment of better drugs for helminth parasites. Hall (1928) 
in his review has given a detailed account of early nemato-
dicidal drugs and ascribed the lack of effective antihelmin-
tics to the absence of critical screening techniques. 
In recent years remarkable success has been achieved with 
the availability of reliable test models and effective and 
safe anthelmintics have been developed as evidenced by the 
exhaustive and comprehensive reviews presented by Standen (1963), 
Cavier and Hawking (1973), Lang (l979), Annon (1979) and more 
recently by Shaima and Charles (1982), This chapter briefly 
reviews the literature on the chemotherapeutic efficacy of 
various antihookwonn drugs with special reference to hookwoitn 
parasites of man. Since the value of Ancylostoma ceylanicum. 
as a screening model for evaluating antihookwonn activity, has 
been established very recently (Ray et al,,, 1978) and only few 
trials have been conducted so &r, the reports on this para-
sites are scanty. However, the reference of experimental 
work employing A, ceylanicum as screening model, vthereever 
available, have been cited. 
Agents effective against hookworms: 
Natural products: 
Among the plant products which were used to treat hook-
worm infections oil of Chenopodium (Chenopodium ambrosioi-
des) is highly toxic and extracts of Anacardiuro occidentale 
is feebly effective. With the availability of new and bet-
ter antihookworm agents, their use has been abandoned. 
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Synthetic products: 
Halogenated hydrocarbons: 
The agents belonging to this group are very effective 
against intestinal nematodes including hookworms, and their 
value has been recognized as early as 1885. Carbon tetra-
chloride and tetrachloroethylene are the most important 
members of this series (Migasena et al^ ., 1978; Sharma and 
Charles, 1982). However, because of their seriouyside ef-
fects such as nausea, vaniting, gastrointestinal disturbdi*^ 
ces and even occasional deaths, these are more or less ex-
cluded from'clinical use. 
Phenols and their alkyl derivatives: 
The chemotherapeutic efficacy of phenols and their al-
kylated derivatives has been reviewed by Cavier and Hawking 
(1973). Of these Disopyrol and Idothymol have moderate to 
good activity against human and animal hookworms (Sanghavi 
and Mistry, 1971; Gandhi et al., 1972; Sen et al.., 1974). 
The phenols cause many toxic side effects and as such they 
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are no more used in clinical practice. 
Cyanine dyes: 
A number of cyanine dyes are known to possess antihook-
woirn activity and of these dithiazanine iodide and stilba-
zium are of sorae iniportance. These dyes have good activity 
against hookworms of dog and cat (Mc Cowen et al.. 1957; 
Burrows and Lillis, 1962; Larcevic et ^ , , 1972). However, 
they are of little value in the treatment of human ancylos-
tomiasis since their administration produces a number of side 
effects such as nausea, vomiting, gastric pain dizziness and 
fever. 
Quaternary ammonium salts (Bephenium salts): 
Bephenium compounds have been shown to possess wide spe-
ctrum activity against intestinal nematodes (Copp et al,«, 1958). 
Of the various salts, bephenium hydroxynaphthoate has species 
specific toxicity, being more effective against A. duodenale 
than against N. americanus (Hsieh, 1970). The usual adult 
dose in man is 5 gram (2.5 gram of the base). 
The main disadvantage of this compound is its bitter 
taste which contributes to frequent vomiting. The drug has 
also been found effective against hookworms of dog and cat 
but because of its unpleasant taste the drug failed to get 
favour with clinicians. 
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Arylisothiocyanates: 
Bitoscanate: 
It is an isothiocyanate derivative, developed by 
Hoechst for the treatment of hookwoim infections. It is 
highly effective against A. duodenale and N, americanus 
(Bhandari and Singh, 1969; Bhandari and Shrimali, 1969; 
1975; Mutalik et al,., 1969). However, because of the 
various side effects (nausea, vomiting, headache, diarzv 
hoea, abdominal pain, weakness and vertigo) noticed in 
humans, the drug has be^i withdrawn from the market. 
Amoscanate: 
Developed by Hindustan Ciba Geigy, this drug has been 
shown to possess efficacy against a variety of intestinal 
parasites including hookworms (Sen, 1976; Doshi et al., 
1977). 
The compound is under advanced clinical phase 3-trials 
(multicentric investigations) and is yet to be released for 
mass use. 
Benzimidazoles: 
The most s ignif icant break thro\jgh in the f i e ld of 
modem anthelmintics was achieved in 1961 when Brown and 
his colleagues reported the unusual broad-spectrum ac t i -
v i ty of benzimidazoles against gastro- intest inal helmin-
ths of man and animals. Among t h e various members of t h i s 
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series, thiabendazole, mebendazole and albendazole have been 
widely used in human practice while the use of other members 
(parbendazole, fenbendazole, oxfenbendazole, carobendazole) 
was limited to veterinary field only. 
The therapeutic efficacy of benzimidazole compounds has 
been adequately reviewed by Ferriot (1978), Lionel (1980), 
Lang (1980) and Shaima and Charles (1982), 
Thiabendazole: 
After the introduction of this compound by Merck in 1961, 
its therapeutic value has been reviewed by Cavier and Hawking 
(1973), The drug has been widely used for the cure and con-
trol of hookworm infections. 
Thiabendazole additionally possesses larvicidal proper^ 
ty, and used against "creeping errupticms* (Manzhgaladze, 
1982), The drug at 25 mg/kg twice a day for two days inocu-
lated subcutaneously in guineapigs was found to be highly 
effective against hookworm larvae (Manzhgaladze, 1982). 
Thiabendazole, has low efficacy against A, ceylanicum 
in hamsters (Ray et,a_l., 1978; Katiyar et al,., 1982; Katiyar 
et a^., 1984), and also shows several side effects in humans 
s\]ch as colic, musculoskeletal pain, nausea, vomiting 
(Chuttani and Ghori, 1969; El-Masry et al.; 1974). It has also 
been reported to cause Jaundice (Sugar et al,, 1980), 
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Mebendazole: 
This is the most promising member of the benzimidazole 
series possessing wide spectrum activity and negligible to-
xicity. Mebendazole is considered as the drug of choice 
for hookworms (Seidel, 1976). The usual dose recommended 
for human hookworms is 100 mg/kg given twice daily for three 
consecutive days. 
The drug was found to inhibit completely the develop-
ment of A. duodenale. N, americanus and A, caninum eggs in 
faecal culture but had no effects on the viability and infe-
ctivity of 3rd stage larvae (Banerjee et al_,, 1971), 
The drug has excellent efficacy against A, cevlanicum 
in hamsters and as low a dose as 2-10 mg/kg was found to 
clear almost all the parasites from the treated hamsters 
(Ray et al,., 1978; Katiyar et al,,, 1982;1984; 1986J. This 
too has some serious drawbacks. Besides the minor effects 
of nausea, vomiting diarrhoea etc., (Gorodner, 1977; Bragov 
et al,, 1978; Bosse and Stoye, 1981), the drug possess embiyo-
toxicity and teratogenicity and as such it is contraindicated 
in pregnancy and children below two years of age (Keystone 
and Murdoch, 1979). 
Albendazole: 
Albendazole, a new benzimidazole derivative i s methyl-
5- propylthio-l-H-benzimidazole-2-yl carbamate. The drug i s 
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being widely used as broad spectrum anthelmintic in veteri-
nary practice (Theodorides et al,,, 1976; Georgi et al.. 
1980). Recently it has been introduced for human use and 
the initial studies have found it to be highly effective 
against ancylostomiasis, ascariasis, enterobiasis, trichu-
riasis and taeniasis in a single dose of 4CX) mg. It has 
also been found effective against Hymenolepis nana and Stron-
qyloides stercoralis vrtien given in a dose of 400 mg for 3 
consecutive doses (Pene et al.., 1982). 
Misra et,a2..f (1983) tested the drug against 56 adult 
patients having single or mixed infections with round worms, 
hookwonns, whipworms, pinworms and tape worms. A single dose 
of 400 mg has given cure rate of 95,1% in ascariasis, 94.1^ 
in ancylostomiasis and 57.2^ in taeniasis. Jagota (1986) 
reported 92.2^ cure rate (130 out of 141 cases) in hookworm 
infection at dose of 400 mg, 
Misra et al., (1985) reported that albendazole suspen-
sion (400 mg in 20 ml) was 100^ effective against 8 mild and 
6 moderate cases of A. duodenale infection. This drug is 
also effective against other helminth parasites. Diarrhoea, 
vomiting, pain in abdomen are the observed side effects of 
the drug. 
This being a recent introduction to human practice not 
much information has been generated. 
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Fenbendazole: 
In the l i s t of ben2imidazole anthelmintics, Hoechst 
added a new highly ef fect ive agent, Fenbendazole in 1974. 
Baeder and his colleagues (1974) investigated i t s anthel-
mintic act ivi ty and i t was found remarkably e f fect ive 
against different species of lung and intest inal nematodes 
(Ouwel, 1978). In dogs, a dose of 20-30 rag/kg was needed 
to bring about 90-1009^ worm reduction in respect of ancy-
lostcanes and ascarids (Gerlach et al^,, 1975), The compound 
i s 983^  effect ive when given a lOP^  oral suspension (25-50 
mg/kg body weight) for 3 days, against A, caninum in dogs 
(Bruke and Roberson 1979). Fenbendazole i s extreme-
ly well tolerated. The LD^Q in rats i s higher than 10,000 
mg^ kg orally and 12,500 mg/kg intraperitoneally, 
Tetrahydropyrimidines: 
Pyrantel pamoate i s the f i r s t member of th i s c lass in-
troduced by the Medical Research Laboratory of Chas-Pfizer 
& Co., Inc. , USA, in la te s i x t i e s under brand name of Com-
(R) 
bantrin^ ' . It shows broad spectrum act iv i ty against ente-
r ic helminths and th i s property has been ascribed to i t s low 
water so lubi l i ty and slow absorption through the gut. 
The ususl do.se of pyrantel pamoate i s 10-100 mg/kg, de-
pending upon the nature and intensity of the infect ion. I t 
was found to be quite e f fect ive against both A, duodenale 
and N. americanus (Past ic ier , 1975). Huggins et al , , i ( l973) 
observed that pyrantel pamoate was more effect ive against 
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A, dxinodenale than N, americanus. 
The drug is well tolerated and a single oral dose 
of 3500 mg did not produce any side effects while a dose 
of 2500 mg for two consecutive days resulted in mild side 
effects like diarrhoea, gas cramps and nausea (Bumbalo 
et al., 1969). 
Imidazothiazoles: 
Tetramisoles developed in 1966 by Thienpont and his 
associates, possess high order of anthelmintic activity. 
The levo-rotatory isomer (levamisole) is more effective 
than its dextrorotatory counter part (Oecaris) (Thienpont 
et al., 1970). The usual dose of tetramisole in man is 
2,5 rag/kg with cure rate to the tune of 809^ . 
In hamsters infected with ^ . ceylanicum. complete cure 
was achieved with levo-rotatory isomer (levamisole) at &-13 
mg/kg and with dextrorotatory isomer (Decaris) at 3-10 mg/kg 
(Misra et BI,, 1981). 
Avermectin ^ : 
Avermectins, the newly discovered antiparasitic agents 
have excellent potency and unique spectrum of activity ag-
ainst nematode and arthropod parasites. These are the macro-
cyclic lactones produced by a new species of actinomycete, 
Streptomvces avermitilis. The fungus actinomycete was first 
isolated in Japan and the efficacy of the fungal concentra-
te was established by Merck Sharpe and Dohme research 
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laboratories against Nematospiroides dubius in nice 
Campbell et^a^,, (1983), 1*^ ® avermectin complex was subse* 
quently analysed and was found to contain numerous frac-
tions, of which the most potent isolate was 22, 23-dihy-
droavermectin B^ ^^ named "ivermectin*. It consists of at 
least 805^  of 22, 23-dihydroavermectin B. and about 20?^  
of 'b* homologue. This combination, being highly effective 
and safe, was pursued for commercial development (Chabala 
et,al^ ,, 1980; Egerton et al.. 1979), 
Ivermectin in very minute quantities possesses high 
efficacy against the nematodes of the following superfami-
lies; Trichostrongyloides, Rhabditoidea, Ascaroidea, Oxyu-
roidea, Spiruroidea, Filaroidea and Trichuroidea (Campbell 
et al.. 1983). It is cent percent effective against A. 
et aT. 
caninum at a dose level of SO-lOOAig/kg (Ya2winskT7^1^82), 
Averroectins paralyse worms by potentiating the inhibi-
tory effect on neu^rotr^mitter gamma-amino-butyric acid 
(GABA). Signals from central nervous syst^n (CMS) are there-
fore, not percieved by the motor neurons resulting in para-
lysis. 
Miscellaneous compounds: 
Some anthelmintics developed from time to time could not 
attract much interest of clinicians because of one or the 
other shortcomings. Few of these considered to be of some 
value are being briefly mentioned here. 
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Diuredason (Sansalid): 
I t i s a new broad spectrum anthelmintic for dog and cat 
(Seidal et al,,, 1976), was found 99-1000$ active against can-
ine and f e l ine hookworms at 20-100 mg/kg b.w. (Todd and Yates, 
1976; Klein and Bradly, 1976; Sasmal and Sinha, 1982). 
VincofOS: 
Compound is 100^ effective at the dose of 18 mg/kg b.w.x 
1 against canine hookworm (Hass and Collins, 1976) and also 
found effective against 4th stage larvae and Juvenile canine 
hookworms (Hass, 1975), 
Febantel: 
It was developed by Bayer in 1978, It eliminates A. 
caninum and Uncinaria stenocephala from dog at a single oral 
dose of 5 mg/kg (Wollweber et al.,, 1978), Corwin et al.. 
(1982) observed 100^ efficacy against A, caninum at 45 mg/kg 
body weight. 
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MATERIALS AND METHODS 
Maintenance of AncylostCMna ceylanicum in golden hamsters 
(Mesocricetus auratus)» 
The basic requirement for any experimental work Oased 
on parasites is to have a suitable laboratory model so that 
the regular supply of parasitic material and infected host 
can be maintained in adequate quantity. 
In the present study, Ancvlostoroa ceylanicum in hamster 
was used as the tesi parasite. 
Life cycle of the parasite: 
A. ceylanicum completes its life cycle exclusively in 
the lumen of the intestine of hamsters. The infective stage 
is the third stage filariform larva and the infection of the 
host occurs by oral administratis of this parasite. Inroa-
ture worms develop in the small intestine of hamsters after 
7 days of infection. Oi day 12 p.i. few gravid females and 
mature males can be seen. Fertile eggs in the faeces could 
be demonstrated as early as day 13 out usually not until 
day 17 p.i. 
Larval culture: 
Faecal pellets were collected froa hamsters carrying adult 
A. ceylanicum. A thin paste of the faecal matter was made 
with distilled water and activated charcoal was mixed in the 
ratio of 1:3. The mixture so obtained was transferred to pe-
tridishes (6" diameter) containing moist filter paper at the 
bottom and sprayed with 0,296 micostatin to check fungal 
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growrth. Petridishes were maintained at 26^-28% and 70-805^  
humidity for 8-10 days. Developed Lg (infective larvae), 
were separated and cleaned tiy baermannization or by repeated 
washing and centrifugation at 1500 r.p.m. 
Counting and preparation of larval inoculum: 
The larval estimate was made using Scott's dilution 
technique considering only the active larvae. Before count-
ing, bulk of larval suspension was diluted with appropriate 
volume of distilled water. The suspension was gently but 
thoroughly shaken to make uniform distribution of larvae in 
the suspension, three larval counts each of 0.1 ml suspen-
sion were made under dissecting microscope and the average 
larvae present in 0.1 ml was used to determine the number of 
larvae present in 1 ml of mother solution. For experimental 
work the stock solution was diluted with distilled water so 
as to obtain the desired number of larvae in 0.2 ml. 
Infection to hamsters: 
Hamsters were kept in plastic cages and housed in animal 
rooms maintained at 25°-28°|0. Standard rodent pallets (Lip-
ton India Limited, Bangalore) and water ad libitum were pro-
vided. 
Hamsters weighing (50-80 g) were used in the experiments, 
60 * 5 Lg in 0.2 ml of distilled water were administered ora-
lly to each hamster using feeding needle (20 gauge) attached 
to a one ml tuberculine syringe. This inoculum resulted into 
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establishment of 25-40 adult worms in the intestine ixnder 
optimum laboratory conditions. 
Experience shows that higher inoculum size is lethal 
to hamsters and lower larval doses yield poor establish-
ment. Thus, 60 + 5 Lg were considered optimum and were 
used for the maintenance of infection and chemotherapeu-
tic testing. 
Preparation of test materials; 
The plant extracts and synthetic compounds were pre-
pared in medicinal chemistry division of CD.R.I, and were 
available for testing their antlhookv/orm activity. The 
plant extracts were solubilized or suspended in water or 
permissible amount of solvents indicated. Similarly, the 
water soluble synthetic compounds were made into solution 
in required amount of water. The insoluble ones were made 
into fine paste with Tween 80 (polyoxy-ethylene sorbitan 
mono-oleate) before making final suspension in requisite 
amount of water. 
Drug testing: 
The drug testing was carried out as per technique be-
ing used in this institute (Misra et al_., 1981; Katiyar 
et al.., 1982; 1984), Briefly, the hamsters harbouring 18-20 
da>' old infection (60 + 5 L^, p.o,) (confirmed by ovoscopic 
exacination) were used for screening purposes. The animals 
were randomized in various experimental and control groups. 
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These were starved over night (to ensure closer contact of 
the drug with parasites in the absence of food material) 
and treated with plant extracts or synthetic compounds at 
the respective dose of 1 g/kg x 1 and 250 mg/kg x 1, using 
3-5 animals at each dose schedule. All experimental and 
control animals 48 hrs later were sacrificed under deep 
•ther anaesthesia having being starved 24 hrs before hand. 
Withdrawl of food facilitated accurate counting of worms. 
Assessment of therapeutic efficacy: 
The therapeutic efficacy was assessed by comparing 
the average number of worms recovered from the treated 
group to that obtained from untreated control group. The 
efficacy was assessed in terms of percent worm reduction 
which was determined by foitnula t^ -n ^ ^ where 'N' 
N 
and *n* stand for the average number of worms recovered 
from the untreated control and treated groups respectively. 
The trials were conducted under optimal experimental condi-
tions to minimise the possible errors in drug testing. The 
plant extracts and synthetic compounds found active in ini-
tial doses were evaluated in lower doses till reasonable 
activity was retained. This exercise helped in selecting 
the most effective corapoonds for elaoorate studies. 
Elaborate investigations of active compounds: 
The efficacy was evaluated against the following para-
sites: 
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AncYlostoma ceylanicum; 
Adulticidal action: 
The drug testing was done as described earlier. The 
activity was assessed after administering drug by oral and 
intraperitoneal routes. 
Larvicidal action: 
The method of infection and medication to animals were 
as per the technique of Katiyar et al,., (1986). Briefly 
the animals were divided in several groups depending on the 
number of doses and stages of parasite against which the 
action of the drug was to be evaluated. The Lj of A, cey-
lanicum moults to L^ on day 2, and from L^ to L^ on day 5 
(Ray and Bhopale, 1972), Therefore, the test canpounds 
(1 and 2) and reference drug, mebendazole were administered 
on day 1, 3 and 6 postinfection (Katiyar et al.., 1984; 1987) 
for evaluating effect on L^ t L^ ^nd L^ stages, respectively. 
The control animals received medium only. The treated and 
untreated hamsters were sacrificed on day 20 post infection 
vthen Lj reached patency in the intestine. The efficacy was 
expressed in terms of absolute clearance of parasite from 
the host and percent worm reduction compared to control group. 
Chemoprophylactic action: 
For evaluating chemoprophylactic potential, naive ham-
sters were injected intramuscularly (i.«) with the test com-
pounds in the dose schedule of 100 and 50 mg/kg b.w. x 1. 
6- 1^ 
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The treated hamsters were challenged with 60 + 5 Lo after 
day 7 and day 15 of treatment. The untreated control ham-
sters were also challenged simultaneously. The hamsters 
were sacrificed on day 20 of challenge to assess the prophy-
lactic effect. 
NipDostronavlus brasiliensis; 
Male rats of UF strain weighing 30-40 g and infected 
subcutaneously with 500 infective larvae (L^) of N. brasi-
liensis served as experimental host (Misra et al,, 1981), 
The compounds in suspension form were given p.o, to rats 
infected 9 days beforei The treated and intreated controls 
were autopsied on the third day of the last dose and their 
worm burden was compared with those obtained from untrea-
ted rats and the efficacy assessed. 
Syphacia obvelata: 
The compounds were evaluated in either sex of Swiss 
albino mice (20^25 g) with naturally acquired infection of 
S_, obvelata (Katiyar et al., 1984), The caecum and colon 
were isolated, incised longitudinally in a petridish and 
examined under the dissecting microscope. The criterion 
of efficacy was the absolute clearance of parasites from 
the treated mice because of wider variation in worm burden. 
Hymenolepis nana; 
The technique followed was that of Gupta, (1981), 
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Briefly, male Swiss mice (20-30 g) were inoculated with 
200 viable ova. On day 20, p.i, the mice found positive 
for the parasite (by ovoscopic examination) were selected 
for screening. The basis of drug efficacy was the complete 
removal of worms with scolices from the treated animals. 
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RESULTS 
The results of preliminary screening of plant extracts 
and synthetic compounds against A» ceylanicum have been 
summarized in Tables 1 and 2, A total number of 11 extra-
cts of plants of different families and 47 synthetic com-
pounds (frOTj different chemical series) were screened. 
These belong to benziniidazoles (13), dihydropyridines (7), 
imidazoles (11), oximinopentanes (2), crotonates (2), pyri-
roidines (6), guanidines (4) and isoxazolines (2). 
Among the plant extracts, none was found to have any 
antihookworm activity. However 9 synthetic compounds (7 
benzimidazoles and 2 imidozoles) were found efficacious at 
the initial dose level. Of the 7 active compounds of benzi-
midazole series No,5, 6, 10, 11, 12 had only partial acti-
vity at the initial dose of 250 mg/kg x 1, while compounds 
1 and 2 showed 1009^  anthelmintic action at this dose level. 
The minimum doses of compounds 1 and 2 exhibiting lOOSi^  
efficacy were 12,5 rag/kg x 1 and 100 mg/kg x 1, respective-
ly. Compounds 1 and 2 at lower doses of 6,25 mg/kg x 1 and 
3.12 mg'kg x 1 exhibited 43,465l£ and 27,55?^  worm reduction, 
respectively. 
Among the imidazoles, compounds 21 and 28 could bring 
down the respective worm burden in treated animals to 51% 
and 90^ only at the initial dose level of 250nig/kg x 1, but 
lost their activity w^en the amount was reduced to 100 mg/kg 
X 1, 
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Compound 1: 
Ancvlostoma cevlanicum: 
Adulticidal activity: 
The activity of compound against adult parasites of 
A. ceylanicum has been presented in Taole 3. All the worms 
from the treated hamsters were cleared by the compound at a 
single oral dose of 12.5 mg/kg x 1, Lower doses showed 
dose dependent efficacy i.e., 43,4?^  and 31.^ worm reduct-
ion at the dose level of 6.25 mg/kg x 1 and 3.12 mg/kg x 1, 
respectively. 
Parenteral administration of the compound also endorsed 
antihookworm activity but it was inferior to that by per os 
route, 1009S efficacy was observed at 50 mg/kg x 1 dose level 
and lower dose showed dose dependent efficacy, 
Larvicidal action: 
Efficacy data aigainst developing parasites of A. cevla-
nicum have been summarized in Tables4 a and b • The results 
demonstrate that the compound was more efficacious against all 
the level stages by oral route compared to intraperitoneal 
administration. At lower doses the compound had proportionate 
efficacy. It seems that L^ stage is more resistant to the 
drug than L^ and L^ stage. Intraperitoneal administratis 
of 50 mg/kg x 1 reduced the worm burden to the extent of 
52,23$^  66,1^ and lOO^ S when assessed against L^, L^ and LR 
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stages of the parasite, respectively. When the lower dose 
of 6,25 mg-'kg x 1 was given intraperitoneally the respecti-
ve worm reduction was 16.3^, 26,7^ and 60.^. 
Chemoprophylactic action: 
Compound at 100 mg/kg b.w/ x 1 dose was found to prote-
ct hamsters (67,8?^  worm reduction) to subsequent challenge 
of Lo up to day 15 (not shown in Table), The lower dose 
(50 mg/kg x l) failed to exert prophylactic action as obser-
ved on day 7 by challenge. 
Nippostronovlus brasiliensis: 
Against N. brasiliensis compound was ineffective even at 
the initial oral dose of 250 mg/kg b.w. x 3, as the worm re-
coveries in treated and untreated control rats was compara-
ble (Table 3). 
Syphacia obvelata: 
At 100 mg/kg x 1 doses, the compound was fully effecti-
ve. In multiple dose schedule 100^ efficacy was observed 
at the dose of 50 mg/kg x 3 and 66^ at 25 mg/kg x 3(Tahle 3). 
Hvmenoleris nana: 
The compound was completely effective at the initial 
dose, of 250 mg/kg x 1 in the rats and 25^ at 100 mg/kg x 1, 
In triple dose schedule 100^ and 83,;^ host clearance was 
found at the respective dose of 50 mg/kg x 3 and 25 mg/kg 
X 3 (Table 3), 
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Compound 2; 
Ancvlostoma cevlanicum; 
Adulticldal activity: 
The compound killed all the adult parasites at a single 
oral dose of 100 mg/kg x 1. At lower dose of 50 mg/kg x 1 
the compound reduced the worm burden to the tune of 99,^• 
Further down doses showed proportionate efficacy. Intra-
peritoneal administration yielded marginally less activity 
(Table 3). 
Larvicidal action: 
A single oral dose of 100 mg/kg x 1 was effective to 
the tune of 72.15^ , 99.2^ and lOOpS against the L3, L^ and 
Lg stages of the parasite, respectively. Lower amouuits 
had corresponding activity. Intraperitoneal route showed 
inferior activity than per os route (Tables 4 a and b). 
Chemoprophylactic action: 
The compound administered at 100 mg/kg intramuscular-
ly (i.m,) did not exert prophylactic action when challenged 
on day 7 of treatment, (not given in table), 
Wippostrongylus brasiliensis; 
The compound was ineffective even at the initial dose 
of 250 mg/kg x 3 against this parasite in rats (Table 3). 
'Syphacia obvelata; 
At a dose of 250 mg/kg the compound cleared all the 
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worms (lOCfiS efficacy) while at 100 mg/kg x 1 only 66.6^ 
animals were freed from parasites. 
In triple dose schedule of 50 ng/kg x 3 and 25 mg/kg 
X 3 IDL and 505^  efficacy was observed (Table 3), 
Hymenolepis nana: 
The compound was effective only at the initial dose 
of 250 mg/kg x 1 in rats while in multiple dose schedule 
(50 mg/kg x 3) lOOP^  efficacy was found (Table 3), 
Table-1, Resultsof in vivo screening of plant extracts 
against Ancvlostoma ceylanicuro in hamsters 
Dose - Ig/kg body weight x 1 
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SI. No. Plant extract Activity 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
Family : Loranthaceae 
Taxillus cuneatus 
(RC) 
Inactive 
Dendrophthae falcata_ Inactive 
(PX) 
Family : Euphorbiaceae 
Mailotus philipplnensis Inactive 
(PX) 
Triqonostemon aurantiacus Inactive 
(PX) 
Macaranqa pustulata Inactive 
(PX) 
Family :Celastraceae 
Maytenus ovatus Inactive 
(PX) 
Microtropis microcarpa Inactive 
(PX) 
Family : Myrtaceae 
Family : Comae eae 
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SI. No. Plant extract Activity 
8. 
10. 
SyzygiuiD occidental is Inactive 
(PX) 
Family : Poaceae 
Arundenaria falcata Inactive 
(PX) 
Family : Salicaceae 
Salix wallichiana Inactive 
(PX) 
11. Toricellia tilliaefolia Inactive 
(PX) 
(PX) - Entire plant without roots. 
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Table-2. Results of in. vivo screening of synthet ic compounds 
agains t A. ceylanicum in hamsters. 
S I . 
No. 
m 
Synthet ic compounds Dose (mg/kg) 
HI SI 
Activi ty in 
terms of % 
worm reduction 
( 4 ) 
BENZIMIDAZOLES 
1. 
2 . 
3 . 
4 . 
Methy 1-5(6)- 2,5-diinethyl-
3 methoxy-carbonyl furano 
benzimidazole-2-carbamate 
(83-148) 
Methy 1-5(6)- 2,5-dimethyl-
3-methoxy-carboByl pyr ro le 
benzimidazole-2-carbamate 
(85/478) 
Methy 1-5(6)- 2,5-dimethyl 
- 3 roethoxy-carbonyl-N-
anisyl pyrrolo benzimida-
zole-2-carbamate (86/144) 
Methyl-5(6)- 2,&-dinjethyl- 250x1 
3-methoxy-carbonyl-N-benzyl-
pyrrolo benzimidazole-2-
carbamate (86/177) 
250x1 
iOOxi 
50x1 
25x1 
12.5x1 
6.25x1 
3.12x1 
1.56x1 
250x1 
100x1 
50x1 
25x1 
12.5x1 
6.25x1 
3.12x1 
1.56x1 
250x1 
100,0 
100.0 
100.0 
100.0 
100,0 
43,4 
31.8 
Inactive 
100.0 
100.0 
99.3 
80.7 
69.4 
27,5 
26.3 
Inactive 
Inactive 
Inact ive 
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(1) ( 2 ) ( 3 ) ( 4 ) 
5. Methy 1 - 5 ( 6 ) - 2 ,5-d imethyl -
3-methoxy-c a rbony 1-N-inet hy 1 
nyrrolo benzin5idlazole-2-
carbamate (86/178) 
6. Methy 1-5(6) 2 ,5 -d imethy l -3 -
methoxy-carbonyl-N-(n-butyl) 
pyrrolo ben2imidazole-2-
carbamate (86/179) 
7. Methy 1 - 5 ( 6 ) - 2 ,5 -d imethy l -3 -
methoxy-carbonyl-N-( 3 , 4 , 5 -
trimethoxy phenyl) pyrrolo 
benzimidazole-2-carbainate 
(86/180) 
250x1 
100x1 
250x1 
100x1 
250x1 
84.0 
Inactive 
88.336 
Inactive 
Inactive 
8. Methy1-5(6)- 2 ,5 -d imethy l -3 -
raethoxy-carbonyl-N(N,N-diethyl 
aninopropyl) pyrrolo benzimi-
dazole-2-carbaniate (86/181) 
250x1 Inact ive 
9 . Methyl-5(6)-N- 2 ,5-di inethyl-
3-methody-carbony1-4-phenyl 
. pyrrolo-benziroida2ole-2-
carbamate (86/212) 
250x1 Inact ive 
10. Methyl-5(6)-N- 2,5-diroethyl-
3-methoxy carbonyl-4-(3 ,4-me-
thoxyphenyl) Pyrrolo benzimi-
dazole-2-carbaroate (86/213) 
11 . Methyl-5( 6 )-N- 2,&-dimethyl-
3-methoxy carbonyl-4 ( p - t o l u o -
y l ) pyrrolo benziinidazole-2-
carbamate (86/214) 
12. Methyl -5(6) - 4 - ( 2 , 6 - d i m e t h y l -
3 , 5 dimethyl carbonyl -1 ,4 -
dihydropyridyl benzimidazole-
2-carbamate t86 /421) 
250x1 
100x1 
250x1 
100x1 
250x1 
100x1 
90?6 
Inactive 
40^ 
Inactive 
5S^ 
Inactive 
3D 
(1^ (2} C3) 
13 Methyl-5(6)-N- 2,5 dimethyl- 250x1 
3-methoxy cart)omyl-4-(p-ace-
tamidophenyl) pyrrolo benzi-
inida2oie-2-carbamate (86/275) 
ni 
Inact ive 
DIHyDROPYRI^I^E 
14, 4-(p-Acetamidorheyl)-2,6-
diirethyl-3,5-dimethoxy carbo-
ny 1-14- d ihy d ropy r id in e 
(86/283) 
250x1 Inact ive 
15. 2,6-Dimethyl-3,5-dimethoxy 
carbonyl-4- te t ra2olo 1,5-1 
quinol ino- l ,4 -d ihydropyr i -
dine (86/286) 
250x1 Inactive 
16. 4- (4-chlor(>-3-nitrophenyl )-
2,6-dimethyl-3,5-dimethoxy 
carbonyl-1, 4-dihydropyri-
dine (86/355) 
250x1 Inactive 
17. 2,6-Diniethyl-3,5-dimethoxy-
carbonyl-4»(4-benzylaraino-
3-nitrophenyl )-l ,4-dihydropy-
r i d ine (86/356) 
250x1 Inactive 
18. 4- (2-chloroquinol ino)-2 ,6-
dimethyl-3,5-dimethoxy car -
bony 1- 1 ,4-dihydropy r id ine 
250x1 Inactive 
19. 4-(4-carboinethoxyphenyl)-3, 
5-dicarbomethoxy-2,6-dimethYl-
1, 4-dihydropyridine(86/360) 
250x1 Inact ive 
20. 2,6-Dimethyl-3,5-dimethoxy-
carbonyl-4-(4-formylphenyl) 
- l ,4-dihydropyr id ine(86/361) 
250x1 Inact ive 
IMIDAZOLES 
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TIT IS nr m 
21 . 5-cycl ohexyl amino-l-methy 1-
4-ni t ro- imidazole (86/516) 250x1 
5135 
22. l -Methyl-4-ni t ro-5-(4-phenyl 
p ipe raz in -1 -y l ) imidazole 
(86/517) 
250x1 Inact ive 
23. 5-(4-Methyl p i p e r a z i n e - l - y l ) 250x1 
- l -me thy l -4 -n i t ro imidazole 
(86/549) 
Inactive 
24. 5-(Carboxymethyl)mercapto-l-
D»ethyl-4-.nitro imidazole ) 
(86/550) 
250x1 Inactive 
25. l-Methyl-4-nitro-5-(piperidin- 250x1 
1-yl) imidazole (86/644) 
Inactive 
26. 5-Anis id ino-l-methy 1-4-nitro 250x1 
imidazole (86/645) 
Inactive 
27, 5-Az id o-l-methy 1-4-nitro 
imidazole (87/11 ) 
250x1 Inactive 
28. 5-Methoxy-l-methyl-4-nitro 
imidazole (87/112) 
250x1 
100x1 
50x1 
9C^ 
5095 
Inact ive 
29. 5-Benzylamino-l-methy1-4-
ni t ro- imidazole (87/113) 
250x1 Inact ive 
30, 5-cyano-l-methy 1-4-nitro 
imidazole T87/l90) 
250x1 Inactive 
Try m m m 
31. 5-Ethoxy-l-iDethyl-4-nitro-
imidazole (87/191) 
250x1 Inactive 
CROTONATES 
32. Methyl-3-aminc>-2(p-raethoxy 250x1 
phenyl) n i t r o ethyl crotonate (86/634) 
Inact ive 
33. Methyl-3-aniino-2-(p-nitrophenyl) 250x1 Inact ive 
n i t roe thy l crotonate (86/637) 
OXIMINDPENTANES 
34, 5-carboinethoxy-4-(p-methoxy 250x1 
phenyl )-5-nitro-2-oximino 
pentane (86/635) 
Inactive 
35, 5-carbomethoxy-4-(3,4-diinetho« 250x1 
xy- pheny 1-5- nit r o-2- ox imino 
pentane (86/636) 
Inact ive 
PYRIMIDINES 
36, 5-Ethoxy carbanyl-2-methyl-
mercapto-6-methyl-4-pheny 1-
4(1 H)-pyrimidine (85/l76) 
250x1 Inact ive 
37, 5-Methoxy carbonyl-2-methyl-
mercapt o-6-niethy 1-4-pheny 1-
4(1 H)-pyrimidine (85/242) 
250x1 Inact ive 
38, 6-Ethoxycarbonyl-7-njethyl-3-
OxO-5-phenyl-2,3-dihydro-5H-
thiazolo 3,2-a pyrimidine 
(85/357) 
250x1 Inactive 
^ \ ? ? o ^ 
^r 
37 
38 
39. 5-Anisyl-6-ethoxycarbonyl-7- 250x1 
methy 1-3- 0x0-2,3-dihydrt>-5H-
thiozolo 3 ,2 , a pyrimidine"" 
(85/380) 
m 
Inact ive 
40. 6-Ethoxycarbonyl-7-methyl-3-
0x0-5-varat ryl -2 ,3-dihydro-
5 H-thiazolo 3,2-a pyrimidine 
(85/381) 
250x1 Inac t ive 
4 1 . 6-Ethoxy carbonyl-7-methyl-
3-0x0-5- (p- to luoyl ) -2 ,3-
dihydro-5-H-thiazolo 3,2-a 
pyrimidine (85/382) ~ 
250x1 Inactive 
GUANIDINES 
42. N-Benzyl-N,I*-dimethoxY carbo-
nyl guanidine (85/355) 
250x1 Inactive 
43. N.N'-Dimethoxy carbony1-N-
(p-methoxy-phenyl) methyl 
guanidine (85/356) 
250x1 Inactive 
44. N,N*-Dimethoxy carbonyl-M-
(3,4-methylene dioxy-phenyl 
methyl) guanidine (85/413) 
250x1 Inactive 
45. N,N»-Dimethoxycarbonyl-N- 250x1 Inact ive 
(3,4-dimethoxy phenyl methyl) 
guanidine (85/414) 
IS0XA20LINES 
46. 3-Methyl-4-piperonylidine-4, 250x1 Inactive 
5-dihydro isoxazolin-5-one (85/415) 
47. 3-Methyl-4-Veratrylidine 4 , 5 - 250x1 Inact ive 
dihydro isoxazolin-5-one 
(85/416) 
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DISCUSSIONS 
In the past for screening of antihookwonn compounds, 
Nematospiroides dubius and Nippostronqylus brasiliensis 
have been freely used (Standen, 1963). Both are trichos-
trongylid nematodes and do not represent true hookworms. 
There was need to have a hookworm parasite in experi-
mental host to obtain better correlation between experi-
mental dijnd clinical situations. In 1972, Ray et al.. 
succeeded in infecting golden hamsters with Ancvlostoma 
ceylanicum and screened a number of antihookworm drugs. 
They recommended its use in antihookworm chemotherapy. In 
1981, Misra let al^ ., have endorsed the suitability of A. 
ceylanicum during their comparative chemotherapeutic tri-
als employing three nematodes, N. dubius. N. brasiliensis 
and A. ceylanicum. They found that N, dubius needed more 
drug for its removal and its responses were inconsistent, 
while N. brasiliensis was relatively resistant to meben-
dazole which is one of the most effective anthelmintics 
used in "ancylostomiasis*. A, ceylanicum being a target 
hookworm parasite and showing high reactivity to mebenda-
zole, was preferred over the other two nematodes for screen-
ing purposes. Subsequently Katiyar and his associates 
(Misra et al., 1981; Katiyar et al., 1982; 1984; 1987) 
have inducted this model for routine screening of agents 
(piant/synthetic) for antihookworm activity. As such in 
the present study A. ceylanicum was used as the test parasite. 
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Published reports indicate that a number of herbal prepara-
tions have been successfully used to combat parasitic scour-
age. Ayurvedic materia medica prescribes specific ways for 
making decoctions and their usage. However, the modem con-
cept is to isolate the active ingredicnt(s) by using latest 
methodology. This exercise is justified, since most of 
the inactive and unwanted material is removed by selective 
fractionation v^ich helps in picking up the most effective 
and non toxic constituents in relatively pure form. During 
the process, however, it is likely that some of the active 
ingredients are denatured and/or inactivated resulting in 
the loss of anthelmintic activity. 
This has been amply proved from the fact that active 
plant materials which are still being used in ayurvedic 
system when subjected to chemical fractionations lose their 
activity. 
Thus failure to detect antihookworm activity in any of 
the plant samples may be due to some of the reasons cited 
above. 
Regarding the synthetic compounds tested in the present 
study, their preparation was rational as the chemical series 
to which they belong have been known to possess antihookworm 
activity. Of these^benzimidazole carbamates are reputed 
for anthelmintic action. 
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Attempts have been made to find out potent compounds 
newly synthesized for antihookworm activity and to remove 
drawbacks of the parent molecules. 
Although a number of human and veterinary anthelmin-
tics have emerged out from 2,5-disubstituted ben^imidazo-
les, a definite correlate between the minor structural re-
quirements and optimal anthelmintic response is yet to 
comeout. The work carried out in the present study is 
complementary to the observations made earlier (Van den 
Bossche et^ al.., 1982; Shazma and Abuzar, 1983 )• The sub-
stituents 2, and 5(6)- positions of the benzimidazole 
play vital role in determining the biological activity. 
At 2-position of the benzimidazole presence of a carbo-
methoxy amino (NHOOOCFL) function has been found to be essen-
tial as replacement of NHCXXXIH^  group by H, au, Cjt H^, 
OH, SF or SCHg functions bring about either lowering or 
loss of anthelmintic activity. 
The anthelmintic action of methyl benzimidazole-2 carba-
mate is greatly influenced by presence of various groups at 
5(6)-positions. The optimal activity in the compounds test-
ed in this study was associated with those benzimidazole 2-
carbamates having a Co-Aryl (compound no,l) function or an 
aryl group directly linked to the benzimidazole nucleus at 
its 5(6)-position (Compound No.2). The present study would 
indicate that the presence of an aryl or hetero aryl function 
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at 5-position is optimal for obtaining high anthelmintic 
activity in compounds related to benzimidazole-Z-carbamates. 
Among the various nitroimidazoles carrying substituents 
at 1,4 and 5 positions, no definite structure activity rela-
tionship could be established as none of the compounds tes-
ted showed any appreciable activity. The inactivity of all 
these compounds may attribute to two points (a) either the 
bulk at 5 position or a substitution at 1 position is play-
ing a major role in determining the anthelmintic activity or 
(b) the mode of action of nitroimidazoles involving oxida-
tion of nitrogroup, by electron transfer from electron tran-
sferring protein, leading to the formation of unstable hydro-
xy lamine that eventually binds with parasite DN^ is not the 
usual mode of anthelmintic action. 
In recent past quite a few acceptable broad spectrum 
anthelmintics have been introduced. Of these mebendazole 
appears to be more effective against intestinal helminths, 
but because of its side effects there are some limitations 
in its general use. There is therefore pressing need to 
develop anthelmintic!s) with wide spectrum of activity and 
suitable for population based chemotherapy. With this idea 
keeping in view the compounds found promising in the primary 
screening were subjected to elaborate study. Canpounds 1 
and 2 have shown high cure rate against A. ceylanicum. S. 
o&velata and H, nana. However^these could not surpass the 
efficacy of mebendazole and hence can not be considered for 
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developing as broad spectrum anthelmintic. 
Despite the fact that the t^st compounds have activity 
against most of the helminth parasites tested, only the de-
tailed investigations against A. cevlanicum were undertaken 
as both the chemical agents had reasonably good efficacy 
against this parasite. The development of A. cevlanicum 
is confined totally to gastrointestinal tract (G.I«T) 
(Ray et al.., 1972) and benzimidazole caroamates anthelmin-
tics being poorly absorbed through G.I, tract (Bhaduri, 
1985; Akhtar, 1987) are fully available to the parasites. 
This is why better effects of these compounds have been 
observed on adults and larvae by oral route of administra-
tion. It is likely that because of the binding of the test 
compounds to blood proteins during paranteral administration, 
these are not availaole at the site of infection in effective 
concentration. However the detailed biological activity 
profile provided some interesting information on the change 
in molecular architecture and the spectrum of activity. 
Change in the heteroatom in these two compounds (Fig.l 
and 2) made a significant effect on the profile of anthel-
mintic activity against intestinal parasites. Since benzi-
•idazole-2-carbamates are known to exhibit their biological 
efficacy by inhibiting tubulin polymerization (Sharma and 
Abuzar, 1983; Bhaduri, 1985) the binding studies of these 
two compounds with parasite tubulin would help to map the 
Fig.1 
Me>- / 0 > . ^ M e 
MCO2C'' V - - -;i N 
N ' ' ^NHC02Me 
H 
Methyl-[5-(2,5-dimethyl-3-methoxycarbonyl f u r -A -y l ) 
-1 H-ben2imida20t-2-yl] carbamate ( I ) 
Mc02C 
Methy l - [5 - (2 .5-d imethy l -3-methoxycarbony lpyr ro l -4-
y l ) - l H-bcnz imidazo l -2-y l ] carbamate • ( I I ) 
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topography of parasite-receptor for evolving the observed 
biological responses. In view of the significant diffe-
rence of activity against nematodes and cestodes, these 
compounds would serve as better tool for understanding 
the difference of tubulins of cestodes and nematodes. It 
would be also interesting to study the bioavailability of 
the test compounds to ascertain the effect of this minor 
structural change. 
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SUMMARY 
Ancylostomiasis is a major health hazard of man 
affecting about 20-259^  of world population. The disease 
in general is confined to regions with tropical and sub-
tropical climatesy low standard of living and poor sani-
tary conditions. In India all favourable conditions for 
growth, multiplication and dissemination of parasites 
exist and as such the incidence of the hookworm is 
exceedingly high. 
The infective larvae during migration cause creeping 
erruptions, pneumonitis bronchospasm and cough. Adult 
worms are voracious blood suckers and cause severe anaemia 
which may terminate some times to death. 
In the absence of suitable biological control methods, 
chemotherapy remains the only tool to overcome parasitic 
scourge. Because of frequent polyparasitism, the develop-
ment of antihookworm drugs possessing polyvalent anthel-
mintic activity is the need of the day. 
With this idea in view newly procured plant extracts 
and rationally synthesized compounds were tested primari-
ly for their antihookworm activity and if found effective, 
were also tested against other helminth parasites to esta-
blish the spectrum of activity. 
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For antihookworm chemotherapy, the test parasite 
Ancvlostoma cevlanicum in hamster was employed. This is 
a hookworm of dog, cat and man and the experimental data 
obtained on this host parasite system have the positive 
correlation with the target parasite, 
A total number of 11 plant extracts and 47 synthetic 
compounds were tested. Out of these, 9 synthetic compounds 
have shown antihookworm activity. Two compounds ^ and 2_ 
were found highly effective against A. ceylanicum v^ich 
in doses of 12.5 mg/kg x 1 and 100 mg/kg x 1 respecti> e^ly 
deparasitized all the treated hamsters. These compounds 
were also found efficacious against metamorphic forms of 
A. ceylanicum both by oral and parenteral routes. 
Efficacy of these compounds were also tested against 
Nippostronavlus brasiliensis (trichostrongylid) in rats, 
Svphacia obvelata (Oxyurid) in mice and Hymenolepis nana 
(cestode) in rats. Both the compounds were found effective 
against £. obvelata. H. nana but not against N. brasiliensis. 
The study of structure activity relationship revealed 
that the change in the heteroatom of the two compounds 
(Fig. 1 and 2) made a significant effect on the profile 
of anthelmintic activity. 
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